TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NVST

Envista Holdings Corp

Healthcare · Medical Instruments & Supplies

23.40$ -1.4% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Envista Holdings Corp (NVST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.5% of the shares are freely tradable; institutional investors hold 113.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 113.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 99.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 8.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 161Mio.

Largest Shareholders

Institutions

Institutions NVST
Name Stake (%) Shares Change (%) Date
BlackRock Inc 11.12 17,852,827 +1.8 03/31/2026
Ariel Investments, LLC 6.11 9,818,177 -9.6 06/30/2026
Dimensional Fund Advisors, Inc. 5.96 9,566,949 -2.2 06/30/2026
Morgan Stanley - Brokerage Accounts 5.47 8,793,137 -0.2 03/31/2026
Vanguard Portfolio Management, LLC 4.71 7,566,721 +0.0 03/31/2026
Vanguard Capital Management, LLC 4.56 7,318,581 +0.0 03/31/2026
Franklin Templeton Inc 4.29 6,894,025 -14.5 03/31/2026
Gates Capital Management Inc 3.46 5,552,383 +3.5 06/30/2026
State Street Corp 3.26 5,228,758 +0.6 03/31/2026

Funds

Funds NVST
Name Stake (%) Shares Change (%) Date
iShares Core S&P Mid-Cap ETF 3.55 5,695,737 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings NVST
Person Role Shares Value As of Type
Keel Paul A Chief Executive Officer 551,304 12,900,514 $ Aug 18, 2026 direct
Hammes Eric D. Chief Financial Officer 99,913 2,337,964 $ Aug 25, 2026 direct
Nilsson Stefan President, Nobel Biocare 61,560 1,440,504 $ Aug 25, 2026 direct
Acurio Veronica President, Orthodontics 48,806 1,142,060 $ Aug 25, 2026 direct
Befidi Robert President, Diagnostics 45,785 1,071,369 $ Aug 25, 2026 direct
Reis Mischa SVP, Strategy & Bus. Dev. 27,321 639,311 $ Aug 20, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 25, 2026 Acurio Veronica President, Orthodontics Other 7,710 27.47 211,794
Aug 25, 2026 Nilsson Stefan President, Nobel Biocare Other 804 27.47 22,086
Aug 25, 2026 Befidi Robert President, Diagnostics Other 5,147 27.47 141,388
Aug 25, 2026 Hammes Eric D. Chief Financial Officer Other 10,885 27.47 299,011
Aug 20, 2026 Reis Mischa SVP, Strategy & Bus. Dev. Sell 8,000 27.50 220,000
Aug 18, 2026 Keel Paul A Chief Executive Officer Other 179,730 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?